Lv3
336 积分 2024-03-26 加入
Improving dual targeting selectivity in T-cell engagers via synapse-gated and affinity-tuned trispecific antibody design
8小时前
待确认
A T cell redirection platform for co-targeting dual antigens on solid tumors
27天前
已完结
TLR2-Mediated Production of IL-27 and Chemokines by Respiratory Epithelial Cells Promotes Bleomycin-Induced Pulmonary Fibrosis in Mice
28天前
已完结
Antibodies to watch in 2026
1个月前
已完结
Fifty years of monoclonals: the past, present and future of antibody therapeutics
1个月前
已完结
Navigating the clinical progress of antibody-drug conjugates: Emerging opportunities and remaining challenges
1个月前
已完结
The making of multispecific immunoglobulins – a clinical perspective
1个月前
已完结
Abstract 1610: A novel and versatile Prodrug T cell engager platform with a novel candidate demonstrating potent and tumor-restricted activity
1个月前
已完结
Multispecific T-cell engagers attract cancer drug developers
1个月前
已完结
Conditionally Activatable Antibody Platforms: Mechanisms, Modalities, and Clinical Translation Potential
2个月前
已完结
皖公网安备34019202002308
